KJIM :: Korean Journal of Internal Medicine

Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan Decoction in the treatment of hepatic fibrosis

Jing-Wei Deng, Su Yuan, Li-Peng Shi, Xin Chen, Jun Liu, Zhi-Wei Chen, Kai-Yue Tan, Qian Yang, Wen-Fu Cao

Journal of Ethnopharmacology.2024; 323: 117730. CrossRef

Splenectomy ameliorates liver cirrhosis by restoring the gut microbiota balance

Ye Jin, Meixin Shi, Jing Feng, Zhengwei Zhang, Bingbing Zhao, Qingyu Li, Ligen Yu, Zhaoyang Lu

Cellular and Molecular Life Sciences.2024;[Epub] CrossRef

Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells

Yang-feng Lv, Chuan-sheng Xie, Zhi-xing Liu, Mei-diao Kang, Yue Liu, Zi-qiang Liao, Yu-long Ji, Rui Zhao, Yan-shu Li, Xiao-yong Wei, Rong-guang Luo, Qun Tang

Biochemical Pharmacology.2024; 222: 116121. CrossRef

Multiparametric MRI-based whole-liver radiomics for predicting early-stage liver fibrosis in rabbits

Xiao-Fei Mai, Hao Zhang, Yang Wang, Wen-Xin Zhong, Li-Qiu Zou

British Journal of Radiology.2024; 97(1157): 964. CrossRef

Course of Esophageal Strictures in Eosinophilic Esophagitis Using Structured Esophagram Protocol

Diana L. Snyder, Jeffrey A. Alexander, Karthik Ravi, Jeff L. Fidler, David A. Katzka

Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet

Yun-Kai Dai, Hai-Na Fan, Kai Huang, Xin Sun, Zhi-Min Zhao, Cheng-Hai Liu

World Journal of Hepatology.2023; 15(9): 1043. CrossRef

Nicotinamide N-methyltransferase and liver diseases

Guangyu Liang, Ying Li, Yan Lin, Xiao Yang, Jiankun Yang, Shaobo Hu, Anding Liu

Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway

Sally E. Abu-Risha, Samia S. Sokar, Heba R. Elbohoty, Alaa E. Elsisi

International Immunopharmacology.2023; 116: 109750. CrossRef

Baseline ALBI Grade Predicts Benefits After Splenectomy for Cirrhotic Patients with Hypersplenism

Qi Zhu, Desheng Chen, Yichao Lou, Xueqian Xie, Yi Wu, Zhaowen Wang, Hongcheng Sun

Journal of Gastrointestinal Surgery.2023; 27(6): 1130. CrossRef

Performance of 2D-shear wave elastography in autoimmune hepatitis-primary biliary cholangitis overlap syndrome

Xuexin Wang, Yingxia Li, Libin Jiang, Mingxia Zhou, Xiaopeng Zhang, Hongtao Wen

Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis

Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili

Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels

Lin Wang, Yiqi Liu, Qixin Gu, Chi Zhang, Lei Xu, Lei Wang, Cuiying Chen, Xueen Liu, Hong Zhao, Hui Zhuang

The mechanism of peach kernel and safflower herb-pair for the treatment of liver fibrosis based on network pharmacology and molecular docking technology: A review

F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway

Yufeng Sun, Lili He, Peiran Guo, Fenghua Li, Bo Wang, Yifan Zhang, Kai An, Ming Peng

Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway

Cheng Wang, Yanfang Liu, Lihong Gong, Xinyan Xue, Ke Fu, Cheng Ma, Yunxia Li

International Journal of Molecular Sciences.2023; 24(15): 12509. CrossRef

Protective Effect of Pomegranate Juice Extract Against Antitubercular Drugs Induced Hepatic Fibrosis

J. Ramesh, Anilkumar Banothu, Kala Kumar Bharani, P. Shivakumar, M. Jeevanalatha, Y. Ravikumar

Vanillic acid alleviates liver fibrosis through inhibiting autophagy in hepatic stellate cells via the MIF/CD74 signaling pathway

Biomedicine & Pharmacotherapy.2023; 168: 115673. CrossRef

A RELAÇÃO DAS CÉLULAS ESTRELADAS NAS PRINCIPAIS ETIOLOGIAS DA CIRROSE HEPÁTICA

Mariana Cassiano Alves, Mário Mezêncio De Morais Júnior, Beatriz de Oliveira Ávila, Hiaggo Filmiano Rocha, Elder Francisco Latorraca, Lucélia Rita Gaudino Caputo

Revista Contemporânea.2023; 3(8): 12054. CrossRef

Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients

Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jae Young Jang, Dong Joon Kim, Eun‐Sook Park, So‐Young Jin, Kyun‐Hwan Kim

Journal of Gastroenterology and Hepatology.2022; 37(2): 378. CrossRef

Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches

Pharmacology & Therapeutics.2022; 234: 108031. CrossRef

Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway

Juan-Juan Li, He-Chun Jiang, Ao Wang, Fang-Tian Bu, Peng-Cheng Jia, Sai Zhu, Lin Zhu, Cheng Huang, Jun Li

European Journal of Pharmacology.2022; 915: 174530. CrossRef

Syedia R. Rahman, James A. Roper, Jane I. Grove, Guruprasad P. Aithal, K. Tao Pun, Andrew J. Bennett

From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation

Qi Liu, Chengqian Lv, Yanan Jiang, Kunpeng Luo, Yang Gao, Jingyang Liu, Xu Zhang, Jan Mohammad Omar, Shizhu Jin

Dynamic network biomarker analysis and system pharmacology methods to explore the therapeutic effects and targets of Xiaoyaosan against liver cirrhosis

Yiyu Lu, Meiyi Li, Qianmei Zhou, Dongdong Fang, Rong Wu, Qingya Li, Luonan Chen, Shibing Su

Journal of Ethnopharmacology.2022; 294: 115324. CrossRef

Usefulness of Noncontrast MRI-Based Radiomics Combined Clinic Biomarkers in Stratification of Liver Fibrosis

Ru Zhao, Hong Zhao, Ya-Qiong Ge, Fang-Fang Zhou, Long-Sheng Wang, Hong-Zhen Yu, Xi-Jun Gong, Alessandro Granito

Canadian Journal of Gastroenterology and Hepatology.2022; 2022: 1. CrossRef

Moringa oleifera Prevents In vivo Carbon Tetrachloride-Induced Liver Fibrosis through Targeting Hepatic Stellate Cells

Supriono Supriono, Handono Kalim, Nur Permatasari, Hani Susianti

Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 824. CrossRef

Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models

Seong Hee Kang, Hyung Joon Yim, Ji-won Hwang, Mi-jung Kim, Young-Sun Lee, Young Kul Jung, Hyungshin Yim, Baek-Hui Kim, Hae-Chul Park, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun

The Korean Journal of Internal Medicine.2022; 37(4): 745. CrossRef

miR‑146b‑5p activation of hepatic stellate cells contributes to the progression of fibrosis by directly targeting HIPK1

Junfeng Xie, Na Cheng, Zhanchao Huang, Xu Shu, Tianxin Xiang

Experimental and Therapeutic Medicine.2022;[Epub] CrossRef

Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway

International Immunology.2022; 34(9): 455. CrossRef

Current strategies for targeted therapy of liver fibrosis

Bulletin of Siberian Medicine.2022; 21(3): 154. CrossRef

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies

Esraa Ali, Andriy Trailin, Filip Ambrozkiewicz, Václav Liška, Kari Hemminki

International Journal of Molecular Sciences.2022; 23(23): 15292. CrossRef

Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease

Joanne Watt, Mary Jo Kurth, Cherith N. Reid, John V. Lamont, Peter Fitzgerald, Mark W. Ruddock

Influence of hepatotropic and metabiotic correction on the spectrum of free fatty acids in experimental toxic liver damage

V.I. Didenko, V.A. Karachynova, I.A. Klenina, Yu.А. Gaidar, N.Yu. Oshmianska, O.I. Hrabovska, O.О. Halinskyi, N.S. Vishnarevskaya

Quantitative evaluation of liver fibrosis based on ultrasound radio frequency signals: An animal experimental study

Guangwen Cheng, Meng Dai, Tianlei Xiao, Tiantian Fu, Hong Han, Yuanyuan Wang, Wenping Wang, Hong Ding, Jinhua Yu

Computer Methods and Programs in Biomedicine.2021; 199: 105875. CrossRef

Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis

Yuwei Zhang, Yang Li, Tong Mu, Nanwei Tong, Ping Cheng

Journal of Cellular and Molecular Medicine.2021; 25(2): 1299. CrossRef

Role of ellagic acid for the prevention and treatment of liver diseases

Venkatasubramanian Aishwarya, Solairaja Solaipriya, Venkatabalasubramanian Sivaramakrishnan

Phytotherapy Research.2021; 35(6): 2925. CrossRef

Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model

Alvi Yasmin, Daniel P. Regan, Lawrence B. Schook, Ron C. Gaba, Kyle M. Schachtschneider

The Space of Disse: The Liver Hub in Health and Disease

Carlos Sanz-García, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Luis Alfonso Arráez-Aybar, Yulia A. Nevzorova, Francisco Javier Cubero

MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells

Li Ma, Junping Liu, Erhui Xiao, Huibin Ning, Kuan Li, Jia Shang, Yi Kang

Use of Texture Analysis on Noncontrast MRI in Classification of Early Stage of Liver Fibrosis

Ru Zhao, Xi-Jun Gong, Ya-Qiong Ge, Hong Zhao, Long-Sheng Wang, Hong-Zhen Yu, Bin Liu, Giovanni Marasco

Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1. CrossRef

Advances in Hepatic Stellate Cells and Hepatic Fibrosis and Its Reverse

Advances in Clinical Medicine.2021; 11(03): 1420. CrossRef

Molecular factors associated with regression of liver fibrosis of alcoholic etiology

Ya. V. Kiseleva, Yu. O. Zharikov, R. V. Maslennikov, Ch. S. Pavlov, V. N. Nikolenko

Terapevticheskii arkhiv.2021; 93(2): 204. CrossRef

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease

Sung-Min Won, Eunju Park, Jin-Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Gebru, SatyaPriya Sharma, Dong-Joon Kim, Ki-Tae Suk

International Journal of Molecular Sciences.2021; 22(15): 8309. CrossRef

LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5

Yuan-Yuan Wu, Sha Wu, Xiao-Feng Li, Shuai Luo, Ao Wang, Su-Qin Yin, Cheng Huang, Jun Li

European Journal of Pharmacology.2021; 911: 174462. CrossRef

Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota

Cheng Wang, Cheng Ma, Ke Fu, Li-Hong Gong, Ya-Fang Zhang, Hong-Lin Zhou, Yun-Xia Li

Hepatotoxicity or hepatoprotection of emodin? Two sides of the same coin by 1H-NMR metabolomics profiling

Lingyu Ruan, Lei Jiang, Wenlong Zhao, Huihui Meng, Qi Zheng, Junsong Wang

Toxicology and Applied Pharmacology.2021; 431: 115734. CrossRef

Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications

Wolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, Markus Grosse Perdekamp, Annette Schmitt-Graeff, Peter Deibert

International Journal of Molecular Sciences.2021; 22(19): 10372. CrossRef

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression

Alessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, Stefano Gitto, Fabio Marra

Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?

Adriana Ahumada, Laura Rayón, Clara Usón, Rafael Bañares, Sonia Alonso Lopez

World Journal of Gastroenterology.2021; 27(40): 6737. CrossRef

The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective

Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher

Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms

Cheng Wang, Cheng Ma, Lihong Gong, Shu Dai, Yunxia Li

European Journal of Pharmacology.2021; 912: 174604. CrossRef

The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection

Hepatic Stellate Cell: A Double-Edged Sword in the Liver

Decellularized liver matrix as substrates for rescue of acute hepatocytes toxicity

Journal of Biomedical Materials Research Part B: Applied Biomaterials.2020; 108(4): 1592. CrossRef

Ultrasound-based liver elastography in the assessment of fibrosis

The effects and mechanism of Aronia melanocarpa Elliot anthocyanins on hepatic fibrosis

Jing Yang, Jun Gao, Wenchen Yu, Ruobing Hao, Jungang Fan, Jie Wei

Journal of Functional Foods.2020; 68: 103897. CrossRef

Anti-hepatofibrotic effects of CGX, a standardized herbal formula: A multicenter randomized clinical trial

Jin-Yong Joung, Hyeong-Geug Kim, Jin-Seok Lee, Jung-Hyo Cho, Yo-Chan Ahn, Dong-Soo Lee, Chang-Gue Son

Biomedicine & Pharmacotherapy.2020; 126: 110105. CrossRef

Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats

Mabrouk A. Abo‐Zaid, Emad S. Shaheen, Ahmed H. Ismail

Journal of Food Biochemistry.2020;[Epub] CrossRef

The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease

Tiantian Chen, Xiaohong Zuo, Shengju Wang, Penglong Yu, Jie Yuan, Shujun Wei, Jiayi Chen, Yue Sun, Yongxiang Gao, Xueping Li

Origin and role of hepatic myofibroblasts in hepatocellular carcinoma

Betul Gok Yavuz, Roberto Carmagnani Pestana, Yehia I. Abugabal, Sunil Krishnan, Jian Chen, Manal M. Hassan, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed O. Kaseb

Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients

Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng

Gastroenterología y Hepatología.2020; 43(9): 526. CrossRef

Ultrasound-based liver elastography: current results and future perspectives

Protective Effect of Spore Powder of Antrodia camphorata ATCC 200183 on CCl4-Induced Liver Fibrosis in Mice

Yilin Ren, Hua-Xiang Li, Lingxi Zhou, Zhen-Ming Lu, Jinsong Shi, Yan Geng, Zheng-Hong Xu

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges

Hong Zhao, Qi Wang, Changling Luo, Ligai Liu, Wen Xie

BioMed Research International.2020; 2020: 1. CrossRef

Some stability results for a model of Hepatitis C including alanine aminotransferase and immune system

International Journal of Biomathematics.2020; 13(08): 2050080. CrossRef

Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients

Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng

Gastroenterología y Hepatología (English Edition).2020; 43(9): 526. CrossRef

Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling

Minyeoung Kweon, Jae Yeon Kim, Ji Hye Jun, Gi Jin Kim

International Journal of Molecular Sciences.2020; 22(1): 239. CrossRef

The Role of the Gut Microbiome in Liver Cirrhosis Treatment

International Journal of Molecular Sciences.2020; 22(1): 199. CrossRef

Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B

D. Liu, J. Li, W. Lu, Y. Wang, X. Zhou, D. Huang, X. Li, R. Ding, Z. Zhang

Clinical Microbiology and Infection.2019; 25(4): 514.e1. CrossRef

Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo

Qinghua Li, Youcheng Ding, Xinlai Guo, Shenggen Luo, Huiren Zhuang, JingE Zhou, Nan Xu, Zhiqiang Yan

Journal of Cellular and Molecular Medicine.2019; 23(3): 1951. CrossRef

Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride

Mohamed E. Mostafa, Ahmed A. Shaaban, Hatem A. Salem

Chemico-Biological Interactions.2019; 302: 53. CrossRef

Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice

Jessica Mae Grindheim, Dario Nicetto, Greg Donahue, Kenneth S. Zaret

Myofibroblast-specific YY1 promotes liver fibrosis

Huan Liu, Shuya Zhang, Suowen Xu, Marina Koroleva, Eric M. Small, Zheng Gen Jin

Biochemical and Biophysical Research Communications.2019; 514(3): 913. CrossRef

MRI as an alternative to serum ferritin for diagnosis of iron overload in children in the context of immune response after stem cell transplantation

Georg W. Wurschi, Hans‐Joachim Mentzel, Karl‐Heinz Herrmann, Ines Krumbein, James F. Beck, Juergen R. Reichenbach, Karim Kentouche

Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’

Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Gopakumar C. Valiathan, Solomon K. John

Journal of Clinical and Translational Hepatology.2019; X(X): 1. CrossRef

Early detection and staging of chronic liver diseases with a protein MRI contrast agent

Mani Salarian, Ravi Chakra Turaga, Shenghui Xue, Maysam Nezafati, Khan Hekmatyar, Jingjuan Qiao, Yinwei Zhang, Shanshan Tan, Oluwatosin Y. Ibhagui, Yan Hai, Jibiao Li, Rao Mukkavilli, Malvika Sharma, Pardeep Mittal, Xiaoyi Min, Shella Keilholz, Liqing Yu,

Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection

Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng

Canadian Journal of Infectious Diseases and Medical Microbiology.2019; 2019: 1. CrossRef

PRIMARY DISABILITY DUE TO LIVER CIRROSIS IN THE GOMEL REGION

A. E. Voropaeva, V. M. Mitsura, Yu. B. Zaporovannyi, E. A. Mosunova

Hepatology and Gastroenterology.2019; 3(2): 151. CrossRef

Lipophagy and liver disease: New perspectives to better understanding and therapy

Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng

Biomedicine & Pharmacotherapy.2018; 97: 339. CrossRef

Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis B

D.‐P. Liu, W. Lu, Z.‐Q. Zhang, Y.‐B. Wang, R.‐R. Ding, X.‐L. Zhou, D. Huang, X.‐F. Li

Journal of Viral Hepatitis.2018; 25(5): 581. CrossRef

Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14

Eszter Regős, Hadeer Hesham Abdelfattah, Andrea Reszegi, László Szilák, Klára Werling, Gábor Szabó, András Kiss, Zsuzsa Schaff, Ilona Kovalszky, Kornélia Baghy

Dysregulation of fibrosis related genes in HCV induced liver disease

Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady

Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets

Devaraj Ezhilarasan, Etienne Sokal, Mustapha Najimi

Hepatobiliary & Pancreatic Diseases International.2018; 17(3): 192. CrossRef

Fagonia indica Repairs Hepatic Damage through Expression Regulation of Toll-Like Receptors in a Liver Injury Model

Fareeha Azam, Nadeem Sheikh, Gibran Ali, Asima Tayyeb

Journal of Immunology Research.2018; 2018: 1. CrossRef

The role of chemerin and vaspin in Egyptian patients with viral hepatitis C

Shawkey Ali, Doha Ellakwa, Sally Emara, Noha El-Sabbagh

New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article

Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour

Middle East Journal of Digestive Diseases.2018; 10(3): 133. CrossRef

Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma

Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C

Ali Afsari, Edward Lee, Babak Shokrani, Tina Boortalary, Zaki A. Sherif, Mehdi Nouraie, Adeyinka O. Laiyemo, Kawtar Alkhalloufi, Hassan Brim, Hassan Ashktorab

Digestive Diseases and Sciences.2017; 62(8): 2159. CrossRef

Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells

Xin Deng, Xing-Qiu Liang, Fei-Guo Lu, Xiao-Fang Zhao, Lei Fu, Jian Liang

World Journal of Gastroenterology.2017; 23(31): 5713. CrossRef

Cellular senescence and liver disease: Mechanisms and therapeutic strategies

Biomedicine & Pharmacotherapy.2017; 96: 1527. CrossRef